Alterations in immune function and reactivity in schizophrenia (SZ) and mood disorders have been found and extensively reviewed [1,2,3]. Reports of immune dysfunction in transcriptomic and proteomic studies of brain tissue have been reported primarily in SZ (reviewed in [4,5]). The majority of studies have analyzed antibodies, cytokines, and blood cell types, and indexed these markers as either an indicator of pro- or anti-inflammatory reactions or secondary responses. These studies have shown a remarkable diversity of findings and some gains in understanding relationships between psychopathology and immune function
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
The Major Histocompatibility Complex (MHC) in Schizophrenia: A Review | 0 | 453 | February 10, 2017 | |
Immune Biomarkers May Advance Personalized Medicine Approaches for Schizophrenia | 0 | 502 | April 29, 2015 | |
A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia | 0 | 290 | March 10, 2019 | |
Is schizophrenia a disorder of the immune system? | 13 | 2258 | August 18, 2016 | |
Truth can be revealed using words. Last post. Goodbye | 2 | 476 | August 5, 2018 |